Krishnan, Suma

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 404

Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study

Biederman, J., Boellner, S. W., Childress, A., Lopez, F. A., Krishnan, S., & Zhang, Y. (2007) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 356

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008) · The Journal of Clinical Psychiatry

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 218

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

Jasinski, D., & Krishnan, S. (2009) · Journal of Psychopharmacology

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 149

Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers

Jasinski, D., & Krishnan, S. (2009) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 100

Long-Term Effectiveness and Safety of Lisdexamfetamine Dimesylate in School-Aged Children with Attention-Deficit/Hyperactivity Disorder

Findling, R. L., Childress, A. C., Krishnan, S., & McGough, J. J. (2008) · CNS Spectrums

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 90

Relative Bioavailability of Lisdexamfetamine 70‐mg Capsules in Fasted and Fed Healthy Adult Volunteers and in Solution: A Single‐Dose, Crossover Pharmacokinetic Study

Krishnan, S., & Zhang, Y. (2008) · The Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismPharmacology and Obesity Treatment

Cited by 73

Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study

Boellner, S. W., Stark, J. G., Krishnan, S., & Zhang, Y. (2010) · Clinical Therapeutics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 72

Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers

Krishnan, S. M., & Stark, J. G. (2008) · Current Medical Research and Opinion

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 55

An Evaluation of the Cytochrome P450 Inhibition Potential of Lisdexamfetamine in Human Liver Microsomes

Krishnan, S., & Moncrief, S. (2007) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 50